Amlodipine Besylate
Brand name: Amlodipine Besylate
Rank #100 of 500 drugs by total cost
$180.1M
Total Cost
20,835,727
Total Claims
$180.1M
Total Cost
147,848
Prescribers
$9
Cost per Claim
6,201,508
Beneficiaries
49,920,055
30-Day Fills
$1,218
Avg Cost/Provider
141
Avg Claims/Provider
About Amlodipine Besylate
Amlodipine Besylate (sold as Amlodipine Besylate) was prescribed 20,835,727 times by 147,848 Medicare Part D providers in 2023, costing the program $180.1M. At $9 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 97 | Hydrocodone/Acetaminophen (Hydrocodone-Acetaminophen) | $185.6M | 8,496,609 |
| 98 | Vibegron (Gemtesa) | $185.2M | 283,953 |
| 99 | Omeprazole (Omeprazole) | $182.7M | 12,147,266 |
| 100 | Amlodipine Besylate (Amlodipine Besylate) | $180.1M | 20,835,727 |
| 101 | Dolutegravir Sodium/Lamivudine (Dovato) | $173.3M | 56,930 |
| 102 | Potassium Chloride (Klor-Con M20) | $172.6M | 6,137,143 |
| 103 | Darunavir/Cob/Emtri/Tenof Alaf (Symtuza) | $172.5M | 34,812 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology